Julie A. Dopheide

1.5k total citations
33 papers, 1.0k citations indexed

About

Julie A. Dopheide is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Clinical Psychology. According to data from OpenAlex, Julie A. Dopheide has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 13 papers in Geriatrics and Gerontology and 6 papers in Clinical Psychology. Recurrent topics in Julie A. Dopheide's work include Schizophrenia research and treatment (14 papers), Pharmaceutical Practices and Patient Outcomes (13 papers) and Attention Deficit Hyperactivity Disorder (5 papers). Julie A. Dopheide is often cited by papers focused on Schizophrenia research and treatment (14 papers), Pharmaceutical Practices and Patient Outcomes (13 papers) and Attention Deficit Hyperactivity Disorder (5 papers). Julie A. Dopheide collaborates with scholars based in United States and France. Julie A. Dopheide's co-authors include Steven R. Pliszka, Glen L. Stimmel, Stephen M. Stahl, A. Mark Williams, Lisa W. Goldstone, Kelan Thomas, Joshua Caballero, Marshall E. Cates, Amy Werremeyer and Ruth E. Nemire and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Bulletin and CNS Drugs.

In The Last Decade

Julie A. Dopheide

29 papers receiving 959 citations

Peers

Countries citing papers authored by Julie A. Dopheide

Since Specialization

Citations

This map shows the geographic impact of Julie A. Dopheide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Dopheide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Dopheide more than expected).

Fields of papers citing papers by Julie A. Dopheide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Dopheide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Dopheide. The network helps show where Julie A. Dopheide may publish in the future.

Co-authorship network of co-authors of Julie A. Dopheide

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Dopheide. A scholar is included among the top collaborators of Julie A. Dopheide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Dopheide. Julie A. Dopheide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insomnia in ambulatory care: A clinical review 2024 ·American Journal of Health-System Pharmacy ·Julie A. Dopheide, W. Roth, (unknown)	0
2	Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth. 2024 ·PubMed ·(unknown), Julie A. Dopheide	0
3	The mental health workforce needs pharmacists 2023 ·American Journal of Health-System Pharmacy ·Julie A. Dopheide, (unknown), (unknown), (unknown), (unknown), (unknown)	3
4	Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic 2023 ·Mental Health Clinician ·(unknown), Julie A. Dopheide, (unknown), (unknown)	2
5	Positioning psychiatric pharmacists to improve mental health care 2022 ·Mental Health Clinician ·Julie A. Dopheide, Amy Werremeyer, (unknown), (unknown), A. Mark Williams	14
6	Antipsychotic Safety in Liver Disease: A Narrative Review and Practical Guide for the Clinician 2022 ·Journal of the Academy of Consultation-Liaison Psychiatry ·(unknown), Julie A. Dopheide	9
7	Pharmacists: Essential partners in shared decision-making for schizophrenia and schizoaffective disorder 2020 ·American Journal of Health-System Pharmacy ·Julie A. Dopheide	1
8	Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy 2020 ·The American Journal of Managed Care ·Julie A. Dopheide	163
9	Curriculum in Psychiatry and Neurology for Pharmacy Programs 2017 ·American Journal of Pharmaceutical Education ·Julie A. Dopheide, Jolene R. Bostwick, Lisa W. Goldstone, Kelan Thomas, Ruth E. Nemire, (unknown), Marshall E. Cates, Joshua Caballero, (unknown), Jacquelyn Bainbridge	26
10	Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department 2016 ·Journal of Psychiatric Practice ·(unknown), Julie A. Dopheide	7
11	Nonpsychiatric Medication Interventions Initiated by a Postgraduate Year 2 Psychiatric Pharmacy Resident in a Patient-Centered Medical Home 2014 ·The Primary Care Companion For CNS Disorders ·A. Mark Williams, Julie A. Dopheide	7
12	Psychiatric Pharmacist Management of Depression in Patients With Diabetes 2013 ·The Primary Care Companion For CNS Disorders ·(unknown), Julie A. Dopheide	6
13	Role of a Psychiatric Pharmacist in a Los Angeles “Skid-Row” safety-net clinic 2011 ·Journal of Urban Health ·(unknown), Julie A. Dopheide, (unknown)	22
14	Psychiatric Pharmacist and Primary Care Collaboration at a Skid-Row Safety-Net Clinic 2011 ·Journal of the National Medical Association ·(unknown), Julie A. Dopheide, (unknown)	13
15	Attention‐Deficit‐Hyperactivity Disorder: An Update 2009 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Julie A. Dopheide, Steven R. Pliszka	448
16	Depression Screening in a University Campus Pharmacy: A Pilot Project 2006 ·Journal of the American Pharmacists Association ·(unknown), Julie A. Dopheide, (unknown), (unknown)	21
17	Psychotropic medication use at a private eating disorders treatment facility: A retrospective chart review and descriptive data analysis 2005 ·Current Therapeutic Research ·(unknown), Julie A. Dopheide	5
18	ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients 2005 ·American Journal of Health-System Pharmacy ·Julie A. Dopheide	11
19	Developing a Partnership With NAMI and Psychiatric Pharmacists 2002 ·Schizophrenia Bulletin ·Kathrine Røe, Julie A. Dopheide, (unknown)	3
20	Gabapentin and Lamotrigine in the Treatment of Bipolar Disorder 1998 ·Journal of the American Pharmaceutical Association (1996) ·Julie A. Dopheide, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact